Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Reynaud-Maurupt

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Substance Use & Misuse|November 27, 2009
The contemporary uses of hallucinogenic plants and mushrooms: a qualitative exploratory study carried out in FranceCatherine Reynaud-Maurupt, Agnès Cadet-Taïrou, Anne Zoll
Journal of Psychoactive Drugs|May 26, 2007
Characteristics and behaviors of ketamine users in France in 2003Catherine Reynaud-Maurupt, Pierre-Yves Bello, Stéphane Akoka, et al.
Presse Medicale (Paris, France : 1983)|May 24, 2005
[High-dose buprenorphine substitution during incarceration.]Catherine Reynaud-Maurupt, Yves Caer, Noëlle Escaffre, et al.
Annales De Medecine Interne|September 10, 2002
Economic and social effects of high-dose buprenorphine substitution therapy. Six-month resultsPierre Lavignasse, William Lowenstein, Philippe Batel, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Substance Use & Misuse|November 27, 2009
The contemporary uses of hallucinogenic plants and mushrooms: a qualitative exploratory study carried out in FranceCatherine Reynaud-Maurupt, Agnès Cadet-Taïrou, Anne Zoll
Journal of Psychoactive Drugs|May 26, 2007
Characteristics and behaviors of ketamine users in France in 2003Catherine Reynaud-Maurupt, Pierre-Yves Bello, Stéphane Akoka, et al.
Presse Medicale (Paris, France : 1983)|May 24, 2005
[High-dose buprenorphine substitution during incarceration.]Catherine Reynaud-Maurupt, Yves Caer, Noëlle Escaffre, et al.
Annales De Medecine Interne|September 10, 2002
Economic and social effects of high-dose buprenorphine substitution therapy. Six-month resultsPierre Lavignasse, William Lowenstein, Philippe Batel, et al.
Pageof 1